Haemophilia A is an inherited condition caused by a lack of factor VIII, an essential substance required for blood to clot and stop bleeding. Monoclonal antibodies are a type of protein that recognize and bind to a target in the body. The medicine prevents bleeding or reduces bleeding episodes in people with this condition.
₦9,100,000.00
Hemlibra 105mg Injection contains the active constituent Emicizumab. It belongs to the class of medications called monoclonal antibodies. It is used to treat patients with haemophilia A who have developed factor VIII inhibitors. It is also indicated to treat severe haemophilia A patients who have not developed factor VIII inhibitors (the FVIII blood level is less than 1%).
Reviews
There are no reviews yet.